Caroline Besley

600 total citations
16 papers, 147 citations indexed

About

Caroline Besley is a scholar working on Oncology, Immunology and Hematology. According to data from OpenAlex, Caroline Besley has authored 16 papers receiving a total of 147 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Oncology, 9 papers in Immunology and 5 papers in Hematology. Recurrent topics in Caroline Besley's work include CAR-T cell therapy research (11 papers), Biosimilars and Bioanalytical Methods (4 papers) and Hematopoietic Stem Cell Transplantation (4 papers). Caroline Besley is often cited by papers focused on CAR-T cell therapy research (11 papers), Biosimilars and Bioanalytical Methods (4 papers) and Hematopoietic Stem Cell Transplantation (4 papers). Caroline Besley collaborates with scholars based in United Kingdom, United States and Spain. Caroline Besley's co-authors include Robin Sanderson, Andrea Kühnl, Maeve O’Reilly, John G. Gribben, Wendy Osborne, Janet Matthews, Ceri Jones, Jessica Okosun, Sunil Iyengar and Claire Roddie and has published in prestigious journals such as Blood, International Journal of Radiation Oncology*Biology*Physics and British Journal of Haematology.

In The Last Decade

Caroline Besley

15 papers receiving 147 citations

Peers

Countries citing papers authored by Caroline Besley

Since Specialization

Citations

This map shows the geographic impact of Caroline Besley's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Caroline Besley with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Caroline Besley more than expected).

Fields of papers citing papers by Caroline Besley

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Caroline Besley. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Caroline Besley. The network helps show where Caroline Besley may publish in the future.

Co-authorship network of co-authors of Caroline Besley

This figure shows the co-authorship network connecting the top 25 collaborators of Caroline Besley. A scholar is included among the top collaborators of Caroline Besley based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Caroline Besley. Caroline Besley is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

#	Work	Indexed citations
1	Older matched sibling donor vs young haploidentical donor for older patients with acute myeloid leukemia 2025 ·Blood Advances ·Xavier Poiré, Myriam Labopin, Emmanuelle Polge, Didier Blaise, Patrice Chevallier, Johan Maertens, Nicolaus Kröger, Caroline Besley, Stéphanie Nguyen, Cristina Castilla‐Llorente, Gèrard Socié, Édouard Forcade, Anne Huynh, Igor Wolfgang Blau, Arnon Nagler, Jaime Sanz, Simona Piemontese, Mohamad Mohty, Fabio Ciceri	2
2	Patient and Caregiver Experiences of CAR T Cell Therapy for Blood Cancer in the UK: A Qualitative Study 2025 ·Patient ·Christel McMullan, Melanie Calvert, Sarah Hughes, (unknown), (unknown), Karen Shaw, Befekadu Asfaw, Caroline Besley, (unknown), Hayley Ellis, Charles S. Farrow, Massimiliano Mazza, Rachel Miller, (unknown), Ceri Jones, (unknown), (unknown), (unknown), (unknown), Olalekan Lee Aiyegbusi	0
3	The Impact of Lymphodepleting Chemotherapy Dose Modifications on Axicabtagene Ciloleucel Expansion and Treatment Outcome in Patients with Relapsed or Refractory CD19-Positive Diffuse Large B-Cell Lymphoma 2024 ·Blood ·(unknown), (unknown), (unknown), Caroline Besley	1
4	Effective bridging therapy can improve CD19 CAR-T outcomes while maintaining safety in patients with large B-cell lymphoma 2023 ·Blood Advances ·Claire Roddie, Lorna Neill, Wendy Osborne, Sunil Iyengar, Eleni Tholouli, David Irvine, Sridhar Chaganti, Caroline Besley, Adrian Bloor, Ceri Jones, Ben Uttenthal, Rod Johnson, Robin Sanderson, (unknown), Maria A. V. Marzolini, William Townsend, Maeve O’Reilly, Amy A. Kirkwood, Andrea Kühnl	64
5	Improved COVID-19 outcomes in CAR-T patients in the age of vaccination and preemptive pharmacotherapeutics 2023 ·Leukemia & lymphoma ·(unknown), Amy A. Kirkwood, Thomas Creasey, Eleni Tholouli, Sridhar Chaganti, Amrith Mathew, (unknown), David Irvine, Caroline Besley, (unknown), Robert Lown, Tobias Menne, William Townsend, Andrea Kühnl, Maeve O’Reilly, Robin Sanderson, Emilie Sanchez, Claire Roddie	2
6	Risk Factors for CD19-Targeting CAR T Manufacturing Failure and Patient Outcomes: A Report from the UK National CAR T Panel 2023 ·Blood ·(unknown), Amy A. Kirkwood, (unknown), (unknown), (unknown), (unknown), Ram Malladi, (unknown), Denise Bonney, Emma Nicholson, Caroline Besley, Sara Ghorashian, (unknown), (unknown), Anne Black, Tobias Menne, Maeve O’Reilly, Robin Sanderson, Sridhar Chaganti	2
7	Brexucabtagene Autoleucel for Relapsed/Refractory Mantle Cell Lymphoma: Real-World Outcomes in the United Kingdom 2022 ·Blood ·Maeve O’Reilly, Robin Sanderson, William Wilson, David Burns, Caroline Besley, Thomas Creasey, Ben Uttenthal, (unknown), Claire Roddie, Andrea Kühnl, (unknown), (unknown), Sunil Iyengar, (unknown), Matthew R. Wilson, Stephen Boyle, (unknown), Graham P. Collins, Rod Johnson, Andrew McMillan	9
8	CAR-T Toxicity Management and Steroid Use in High-Grade B-Cell Lymphoma: Impact on Real-World Survival Outcomes in the UK 2021 ·Blood ·Robin Sanderson, Andrea Kühnl, Eleni Tholouli, Tobias Menne, Amit Patel, Sridhar Chaganti, Caroline Besley, Emma Nicholson, Anne‐Louise Latif, Ceri Jones, (unknown), (unknown), Amrith Mathew, (unknown), (unknown), Lorna Neill, (unknown), Katarzyna Aleksandra Jalowiec, Claire Roddie, Maeve O’Reilly	6
9	Radiotherapy Bridging in Patients With R/R High-Grade Lymphoma Receiving CD19 CAR-T in the UK 2021 ·International Journal of Radiation OncologyBiologyPhysics ·Andrea Kühnl, G. Mikhaeel, Amy A. Kirkwood, Tobias Menne, J. Frew, Eleni Tholouli, (unknown), Caroline Besley, (unknown), Ayşe Latif, N. O’Rourke, Emma Nicholson, (unknown), Sridhar Chaganti, Andrea Stevens, Maria A. V. Marzolini, Roderick J. Johnson, Robin Sanderson, (unknown), Claire Roddie	5
10	OUTCOME OF LARGE B‐CELL LYMPHOMA PATIENTS FAILING CD19 TARGETED CAR‐T THERAPY 2021 ·Hematological Oncology ·Andrea Kühnl, Amy A. Kirkwood, Maeve O’Reilly, Robin Sanderson, Eleni Tholouli, Anand Patel, Caroline Besley, Sunil Iyengar, Ceri Jones, Ayşe Latif, Jane E. Norman, Wendy Osborne, Graham P. Collins, Andrew McMillan, Kirit M. Ardeshna, Sridhar Chaganti, Tobias Menne	5
11	Detection of CAR‐T19 cells in peripheral blood and cerebrospinal fluid: An assay applicable to routine diagnostic laboratories 2021 ·Cytometry Part B Clinical Cytometry ·Ulrika Johansson, Kathleen Gallagher, (unknown), Marcela V. Maus, Keagan S. Casey, (unknown), Matthew J. Frigault, Jennifer Yam, (unknown), Caroline Besley, Sanne Lugthart	3
12	Retinoic acid–responsive CD8 effector T cells are selectively increased in IL-23–rich tissue in gastrointestinal GVHD 2020 ·Blood ·Jennifer Ball, Andrew Clear, (unknown), (unknown), Caroline Besley, (unknown), Andrew J. Stagg, James O. Lindsay, Jamie Cavenagh, (unknown), John G. Gribben, Jeff Davies	7
13	Inotuzumab ozogamicin versus FLAG-Ida in the treatment of relapsed or refractory B-cell acute lymphoblastic leukemia – real-world resource use data 2019 ·Leukemia & lymphoma ·(unknown), Caroline Besley, Rachael Hough, Asim Khwaja, Caroline L. Furness, David I. Marks, Adele K. Fielding	2
14	Inhibition of phosphatidylinositol-3-kinase by the furanosesquiterpenoid hibiscone C 2017 ·Bioorganic & Medicinal Chemistry Letters ·Caroline Besley, (unknown), (unknown), (unknown), Jason S Rawlings	7
15	Durable graft‐versus‐leukaemia effects without donor lymphocyte infusions – results of a phase II study of sequential T‐replete allogeneic transplantation for high‐risk acute myeloid leukaemia and myelodysplasia 2017 ·British Journal of Haematology ·Jeff Davies, (unknown), Shah‐Jalal Sarker, Caroline Besley, Heather Oakervee, Matthew Smith, David Taussig, John G. Gribben, Jamie Cavenagh	4
16	TNFRSF14 aberrations in follicular lymphoma increase clinically significant allogeneic T-cell responses 2016 ·Blood ·(unknown), Jessica Okosun, Caroline Besley, Sameena Iqbal, Janet Matthews, Jude Fitzgibbon, John G. Gribben, Jeffrey K. Davies	28

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact